Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases

Area of Science:

• Biomedical Engineering
• Cardiology
• Nanomedicine

Background:

• Cardiovascular disease (CVD) is a leading global cause of death, with current pharmaceutical treatments often limited by poor pharmacokinetics and high toxicity.
• Nanoparticle-based drug delivery systems, successful in cancer therapy, show promise for improving cardiovascular disease management.
• Existing treatments for cardiovascular diseases face challenges related to drug efficacy and patient safety.

Purpose of the Study:

• To review the therapeutic potential of nanoparticle drug delivery systems in cardiovascular diseases.
• To explore the application of nanomedicine for treating cardiovascular conditions.
• To discuss the role of nanoparticles in modulating metabolism and toxicity for safer cardiovascular therapies.

Main Methods:

• Review of current literature on nanoparticle-based drug delivery for cardiovascular diseases.
• Analysis of metal-, lipid-, and polymer-based nanoparticles for cardiovascular therapeutics.
• Examination of nanoparticle-mediated alterations in drug biodistribution and release kinetics.

Main Results:

• Nanoparticle systems enable site-specific delivery and controlled release of cardiovascular drugs, enhancing therapeutic effects.
• Various nanoparticle types (metal, lipid, polymer) are suitable for cardiovascular applications.
• Nanoparticles can potentially improve drug metabolism and reduce toxicity in cardiovascular treatment.

Conclusions:

• Nanoparticle drug delivery presents a promising strategy to overcome limitations of conventional treatments for cardiovascular diseases.
• Further research into nanomedicine applications can lead to safer and more effective cardiovascular therapies.
• Understanding nanoparticle interactions with biological systems is crucial for optimizing cardiovascular disease treatment.